SciTransfer
Organization

DWI LEIBNIZ-INSTITUT FUR INTERAKTIVE MATERIALIEN EV

Leibniz institute engineering responsive hydrogels, soft matter, and bioprinted tissue systems — from molecular design to biomedical translation.

Research institutehealthDE
H2020 projects
13
As coordinator
7
Total EC funding
€12.3M
Unique partners
77
What they do

Their core work

DWI is a Leibniz research institute in Aachen specializing in interactive and responsive materials — polymers, hydrogels, and soft matter systems that can sense, adapt, or actuate in response to their environment. Their core work spans from fundamental polymer science to applied biomedical materials, including injectable hydrogels for tissue repair, bioprinting of complex tissue architectures, and supramolecular chemistry for drug delivery and bioimaging. They also provide European-level research infrastructure for soft matter characterization (scattering, spectroscopy, rheology), making them both a research producer and a service provider for the broader materials science community.

Core expertise

What they specialise in

Responsive hydrogels and biomimetic soft materialsprimary
5 projects

Core theme across BIOGEL, ANISOGEL, Jellyclock, ConFluReM, and PeriGO — all coordinator-led projects focused on hydrogel engineering and responsive polymer systems.

3D bioprinting and tissue engineeringprimary
3 projects

ORGANTRANS (organoid transplantation), BioArchitecture (bioprinting complex tissue architectures), and ANISOGEL (spinal cord repair) demonstrate deep capability in biofabrication.

Supramolecular and dynamic covalent chemistryprimary
2 projects

SUPRABIOTICS (supramolecular protective groups for antibiotics) and ULTIMATE (atomically precise 2D materials via dynamic covalent chemistry) show expertise in designed molecular assembly.

Soft matter characterization infrastructuresecondary
1 project

EUSMI provides European-scale infrastructure for spectroscopy, scattering, and imaging of soft matter — DWI contributes its characterization facilities to the community.

Extracellular vesicle-based biomaterialsemerging
2 projects

EVPRO (extracellular vesicle-loaded hydrogel coatings for implants) and PArtCell (artificial cells for drug screening) signal a move toward biologically functional material systems.

2D functional materialsemerging
1 project

ULTIMATE explores bottom-up synthesis of atomically precise 2D materials for energy and electronics — a departure from their biomedical core.

Evolution & trajectory

How they've shifted over time

Early focus
Responsive materials and polymer physics
Recent focus
Bioprinting and tissue engineering

In the early H2020 period (2015–2018), DWI focused on fundamental responsive material science — self-propelling soft colloids, morphing materials, biomimetic hydrogels, and membrane fluid dynamics, largely through prestigious ERC grants. From 2019 onward, a clear shift toward translational biomedical applications emerged: 3D bioprinting, tissue models, extracellular vesicle coatings for implants, organoid transplantation, and artificial cells for drug screening. The institute has moved from asking "how do we make materials respond?" to "how do we build functional biological structures with them?"

DWI is converging its hydrogel and soft matter expertise toward regenerative medicine and biofabrication — expect future work in organ-on-chip, implant coatings, and advanced tissue models.

Collaboration profile

How they like to work

Role: consortium_leaderReach: European16 countries collaborated

DWI leads more often than it follows — 7 of 13 projects as coordinator, including all their ERC grants, which signals strong PI-driven research leadership. Their 77 unique partners across 16 countries show a broad European network, though they are not locked into repeat partnerships. For potential collaborators, this means DWI is comfortable building and managing consortia, but also willing to contribute specialist materials expertise as a partner in larger teams.

DWI has collaborated with 77 distinct partners across 16 countries, reflecting a wide European reach typical of a Leibniz institute with strong ERC funding. Their network spans academic, clinical, and industrial partners, with particular density in Western Europe.

Why partner with them

What sets them apart

DWI sits at a rare intersection: they combine deep polymer physics and soft matter expertise with hands-on biomedical translation, all within a single institute. Unlike university labs that specialize narrowly, DWI covers the full chain from molecular design to tissue-scale biofabrication. Their affiliation with RWTH Aachen — one of Europe's top technical universities — and their role in European soft matter infrastructure (EUSMI) gives them both academic credibility and practical access to advanced characterization tools that few partners can match.

Notable projects

Highlights from their portfolio

  • ConFluReM
    Largest single grant (EUR 2.5M ERC Advanced Grant) on controlling fluid resistance at membranes — reflects DWI's top-tier fundamental research capacity.
  • BioArchitecture
    ERC Proof of Concept grant for bioprinting complex tissue architectures, directly translating earlier ANISOGEL research into a commercializable direction.
  • Jellyclock
    EUR 2.28M ERC grant on light-actuated self-pulsing microgels — a striking example of bioinspired materials that blur the line between chemistry and biology.
Cross-sector capabilities
Advanced manufacturing (bioprinting, nanocomposites, surface coatings)Energy and electronics (2D functional materials)Research infrastructure (soft matter characterization services)Pharmaceuticals (drug screening via artificial cells)
Analysis note: Strong profile with 13 projects and clear thematic coherence. Several early projects lack keyword data, so evolution analysis relies partly on project titles and descriptions. The single third-party participation (CO-PILOT) and one infrastructure project (EUSMI) suggest occasional roles outside their core, but the dominant pattern is clear: PI-led responsive materials research trending toward biomedical applications.